Kirk C Hansen

Author PubWeight™ 46.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009 4.83
2 An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005 2.11
3 Comprehensive analysis of a multidimensional liquid chromatography mass spectrometry dataset acquired on a quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometer: II. New developments in Protein Prospector allow for reliable and comprehensive automatic analysis of large datasets. Mol Cell Proteomics 2005 2.06
4 An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2014 1.51
5 Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J Mol Biol 2004 1.34
6 Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol. Proteomics 2005 1.30
7 Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008 1.27
8 A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor. Nat Cell Biol 2010 1.25
9 Proteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph. Surgery 2009 1.20
10 Collagen architecture in pregnancy-induced protection from breast cancer. J Cell Sci 2013 1.12
11 Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 2004 1.08
12 Comprehensive analysis of a multidimensional liquid chromatography mass spectrometry dataset acquired on a quadrupole selecting, quadrupole collision cell, time-of-flight mass spectrometer: I. How much of the data is theoretically interpretable by search engines? Mol Cell Proteomics 2005 1.07
13 Bioinformatic methods to exploit mass spectrometric data for proteomic applications. Methods Enzymol 2005 1.03
14 Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Res 2009 0.99
15 Proteomic analysis of human mesenteric lymph. Shock 2011 0.98
16 Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury. J Trauma Acute Care Surg 2015 0.98
17 The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004 0.97
18 Plasma first in the field for postinjury hemorrhagic shock. Shock 2014 0.97
19 Degradation of some polyubiquitinated proteins requires an intrinsic proteasomal binding element in the substrates. J Biol Chem 2009 0.96
20 Proteomic analyses of human plasma: Venus versus Mars. Transfusion 2011 0.95
21 Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock 2015 0.94
22 Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res 2012 0.94
23 Post-translational modifications and lipid binding profile of insect cell-expressed full-length mammalian synaptotagmin 1. Biochemistry 2011 0.91
24 AKT regulates BRCA1 stability in response to hormone signaling. Mol Cell Endocrinol 2010 0.91
25 Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics 2006 0.88
26 Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron. J Biol Chem 2012 0.88
27 Comprehensive in vivo RNA-binding site analyses reveal a role of Prp8 in spliceosomal assembly. Nucleic Acids Res 2013 0.88
28 Dynamic changes in rat mesenteric lymph proteins following trauma using label-free mass spectrometry. Shock 2014 0.88
29 Proteomic profiling of the mesenteric lymph after hemorrhagic shock: Differential gel electrophoresis and mass spectrometry analysis. Clin Proteomics 2010 0.87
30 Rejuvenation of chondrogenic potential in a young stem cell microenvironment. Biomaterials 2013 0.87
31 Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome. Am J Respir Crit Care Med 2007 0.87
32 GeLC-MS/MS analysis of complex protein mixtures. Methods Mol Biol 2014 0.86
33 Conversion of a mechanosensitive channel protein from a membrane-embedded to a water-soluble form by covalent modification with amphiphiles. J Mol Biol 2004 0.85
34 Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans. J Appl Physiol (1985) 2013 0.85
35 Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion. Crit Care Med 2008 0.84
36 Functional complexity of the axonal growth cone: a proteomic analysis. PLoS One 2012 0.84
37 Gelsolin is depleted in post-shock mesenteric lymph. J Surg Res 2007 0.82
38 Glutamine metabolism drives succinate accumulation in plasma and the lung during hemorrhagic shock. J Trauma Acute Care Surg 2016 0.81
39 It's not your grandfather's field plasma. Surgery 2012 0.81
40 Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. J Trauma Acute Care Surg 2015 0.80
41 Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid. J Trauma Acute Care Surg 2015 0.78
42 Plasma First Resuscitation Reduces Lactate Acidosis, Enhances Redox Homeostasis, Amino Acid and Purine Catabolism in a Rat Model of Profound Hemorrhagic Shock. Shock 2016 0.77
43 Plasma succinate is a predictor of mortality in critically injured patients. J Trauma Acute Care Surg 2017 0.77
44 The Metabolopathy of Tissue Injury, Hemorrhagic Shock and Resuscitation in a Rat Model. Shock 2017 0.75
45 Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells. J Biol Chem 2016 0.75
46 Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator. J Trauma Acute Care Surg 2017 0.75